Baligh R Yehia1, Benjamin French, John A Fleishman, Joshua P Metlay, Stephen A Berry, P Todd Korthuis, Allison L Agwu, Kelly A Gebo. 1. *Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; †Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA; ‡Philadelphia Veterans Affairs Center for Health Equity Research and Promotion, Philadelphia, PA; §Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; ‖Center for Financing, Access, and Cost Trends, Agency for Healthcare Research and Quality, Rockville, MD; ¶Department of Medicine, Massachusetts General Hospital, Boston, MA; #Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD; and **Department of Medicine, Oregon Health and Sciences University, Portland, OR.
Abstract
BACKGROUND: Retention in care is important for all HIV-infected patients, but may be more important for people with advanced HIV disease. We evaluated whether the association between retention in care and viral suppression differed by HIV disease severity. METHODS: A repeated cross-sectional analysis (2006-2011) involving 35,433 adults at 18 US HIV clinics. Multivariable logistic regression models examined associations between retention measures [Health Resources and Services Administration (HRSA) retention measure, 6-month gap, and 3-month visit constancy] and viral suppression (HIV-1 RNA ≤ 400 copies/mL) for HIV disease severity groups defined by CD4 counts: ≤ 200, 201-350, 351-500, and >500 cells per cubic millimeter. RESULTS: Overall, patients met the HRSA measure in 84% of person-years, did not have a 6-month gap in 76%, and had visits in all 4 quarters in 37%; patients achieved viral suppression in 72% of person-years. The association between retention in care and viral suppression differed by disease severity, and was strongest for patients with lower CD4 counts: ≤ 200 [adjusted odds ratio (AOR) = 2.33, 95% confidence interval (CI): 2.16 to 2.51], 201-350 (AOR = 1.96, CI: 1.81 to 2.12), 351-500 (AOR = 1.65, CI: 1.53 to 1.78), and >500 cells per cubic millimeter (AOR = 1.22, CI: 1.14 to 1.30) using the HRSA retention measure as a representative example. CONCLUSIONS: This is one of the first studies to report the impact of HIV disease severity on retention in care and viral suppression, demonstrating that retention in care is more strongly associated with viral suppression in patients with lower CD4 counts. These results have important implications for improving the health of patients with advanced HIV disease and for test and treat approaches to HIV prevention.
BACKGROUND: Retention in care is important for all HIV-infectedpatients, but may be more important for people with advanced HIV disease. We evaluated whether the association between retention in care and viral suppression differed by HIV disease severity. METHODS: A repeated cross-sectional analysis (2006-2011) involving 35,433 adults at 18 US HIV clinics. Multivariable logistic regression models examined associations between retention measures [Health Resources and Services Administration (HRSA) retention measure, 6-month gap, and 3-month visit constancy] and viral suppression (HIV-1 RNA ≤ 400 copies/mL) for HIV disease severity groups defined by CD4 counts: ≤ 200, 201-350, 351-500, and >500 cells per cubic millimeter. RESULTS: Overall, patients met the HRSA measure in 84% of person-years, did not have a 6-month gap in 76%, and had visits in all 4 quarters in 37%; patients achieved viral suppression in 72% of person-years. The association between retention in care and viral suppression differed by disease severity, and was strongest for patients with lower CD4 counts: ≤ 200 [adjusted odds ratio (AOR) = 2.33, 95% confidence interval (CI): 2.16 to 2.51], 201-350 (AOR = 1.96, CI: 1.81 to 2.12), 351-500 (AOR = 1.65, CI: 1.53 to 1.78), and >500 cells per cubic millimeter (AOR = 1.22, CI: 1.14 to 1.30) using the HRSA retention measure as a representative example. CONCLUSIONS: This is one of the first studies to report the impact of HIV disease severity on retention in care and viral suppression, demonstrating that retention in care is more strongly associated with viral suppression in patients with lower CD4 counts. These results have important implications for improving the health of patients with advanced HIV disease and for test and treat approaches to HIV prevention.
Authors: Michael J Mugavero; K Rivet Amico; Andrew O Westfall; Heidi M Crane; Anne Zinski; James H Willig; Julia C Dombrowski; Wynne E Norton; James L Raper; Mari M Kitahata; Michael S Saag Journal: J Acquir Immune Defic Syndr Date: 2012-01-01 Impact factor: 3.731
Authors: Baligh R Yehia; John A Fleishman; Joshua P Metlay; P Todd Korthuis; Allison L Agwu; Stephen A Berry; Richard D Moore; Kelly A Gebo Journal: AIDS Date: 2012-06-01 Impact factor: 4.177
Authors: Baligh R Yehia; Kelly A Gebo; Perrin B Hicks; P Todd Korthuis; Richard D Moore; Michelande Ridore; William Christopher Mathews Journal: AIDS Patient Care STDS Date: 2008-12 Impact factor: 5.078
Authors: Kimberly B Ulett; James H Willig; Hui-Yi Lin; Justin S Routman; Sarah Abroms; Jeroan Allison; Ashlee Chatham; James L Raper; Michael S Saag; Michael J Mugavero Journal: AIDS Patient Care STDS Date: 2009-01 Impact factor: 5.078
Authors: Robert A Bonacci; Katherine Frasca; Lyles Swift; Daohang Sha; Warren B Bilker; Laura Bamford; Baligh R Yehia; Robert Gross Journal: AIDS Behav Date: 2016-05
Authors: Gary Marks; Unnati Patel; Michael J Stirratt; Michael J Mugavero; William C Mathews; Thomas P Giordano; Nicole Crepaz; Lytt I Gardner; Cynthia Grossman; Jessica Davila; Meg Sullivan; Charles E Rose; Christine OʼDaniels; Allan Rodriguez; Andrew J Wawrzyniak; Matthew R Golden; Shireesha Dhanireddy; Jacqueline Ellison; Mari-Lynn Drainoni; Lisa R Metsch; Edward R Cachay Journal: J Acquir Immune Defic Syndr Date: 2016-10-01 Impact factor: 3.731
Authors: Carol W Holtzman; Judy A Shea; Karen Glanz; Lisa M Jacobs; Robert Gross; Janet Hines; Karam Mounzer; Rafik Samuel; Joshua P Metlay; Baligh R Yehia Journal: AIDS Care Date: 2015-02-11
Authors: Anne K Monroe; Lindsey P Happ; Nabil Rayeed; Yan Ma; Maria J Jaurretche; Arpi S Terzian; Kevin Trac; Michael A Horberg; Alan E Greenberg; Amanda D Castel Journal: Clin Infect Dis Date: 2020-10-23 Impact factor: 9.079
Authors: Jonathan Colasanti; Natalie Stahl; Eugene W Farber; Carlos Del Rio; Wendy S Armstrong Journal: J Acquir Immune Defic Syndr Date: 2017-02-01 Impact factor: 3.731
Authors: Lana Lee; Baligh R Yehia; Aditya H Gaur; Richard Rutstein; Kelly Gebo; Jeanne C Keruly; Richard D Moore; Ank E Nijhawan; Allison L Agwu Journal: AIDS Patient Care STDS Date: 2016-03-16 Impact factor: 5.078
Authors: Peter F Rebeiro; Keri N Althoff; Bryan Lau; John Gill; Alison G Abraham; Michael A Horberg; Mari M Kitahata; Baligh R Yehia; Hasina Samji; John T Brooks; Kate Buchacz; Sonia Napravnik; Michael J Silverberg; Anita Rachlis; Kelly A Gebo; Timothy R Sterling; Richard D Moore; Stephen J Gange Journal: Am J Epidemiol Date: 2015-11-17 Impact factor: 4.897
Authors: Eva A Enns; Cavan S Reilly; Beth A Virnig; Karen Baker; Nicholas Vogenthaler; Keith Henry Journal: AIDS Patient Care STDS Date: 2016-09 Impact factor: 5.078